Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based In Vitro Diagnostics : Guidance for Stakeholders and Food and Drug Administration Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 13, 2018
April 9, 2019
d566c877-a6de-457c-a6e7-df0e3cbbe1f9
Related Documents
Considerations for Design, Development, and Analytical Validation of Next Generation Sequencing (NGS) - Based In Vitro Diagnostics (IVDs) Intended to Aid in the Diagnosis of Suspected Germline Diseases: Guidance for Stakeholders and Food and Drug Administration Staff
Guidance DocumentApril 13, 2018Center for Devices and Radiological Health
Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not Individually Identifiable : Guidance for Sponsors, Institutional Review Boards, and Food and Drug Administration Staff
Guidance DocumentApril 25, 2006Center for Devices and Radiological Health
Administrative Procedures for CLIA Categorization: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentOctober 2, 2017Center for Devices and Radiological Health
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.